Natalia Lomakina

Dr. Natalia Lomakina

The Gamaleya National Center of Epidemiology and Microbiology of the Russian Ministry of Health
orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2018 in Virology
Verified
Journal Article
Closed access
AGAlexandra Gambaryan
Alexandra Gambaryan
TMTatyana Y. Matrosovich
Tatyana Y. Matrosovich
EBElisaveta Y. Boravleva
Elisaveta Y. Boravleva
Natalia LomakinaNatalia Lomakina
Natalia Lomakina
SYSvetlana S. Yamnikova
Svetlana S. Yamnikova
MMMikhail Matrosovich
Mikhail Matrosovich

27 May 2021 in Viruses
Verified
Journal Article
Open access
PDF file
YPYulia Postnikova
Yulia Postnikova
ATAnastasia Treshchalina
Anastasia Treshchalina
EBElizaveta Boravleva
Elizaveta Boravleva
AGAlexandra Gambaryan
Alexandra Gambaryan
AIAydar Ishmukhametov
Aydar Ishmukhametov
Natalia LomakinaNatalia Lomakina
Natalia Lomakina
Influenza A viruses (IAVs) evolve via point mutations and reassortment of viral gene segments. The patterns of reassortment in different host species differ considerably. We investigated the genetic diversity of IAVs in wild ducks and compared it with the viral diversity in gulls. The complete genomes of 38 IAVs of H1N1, H1N2, H3N1, H3N2, H3N6, H3N8, H4N6, H5N3, H6N2, H11N6, and H11N9 subtypes isolated from wild mallard ducks and gulls resting in a city pond in Moscow, Russia were sequenced. The analysis of phylogenetic trees showed that stable viral genotypes do not persist from year to year in ducks owing to frequent gene reassortment. For comparison, similar analyses were carried out using sequences of IAVs isolated in the same period from ducks and gulls in The Netherlands. Our results revealed a significant difference in diversity and rates of reassortment of IAVs in ducks and gulls.

23 September 2011 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
PDF file
AGAlexandra S. Gambaryan
Alexandra S. Gambaryan
Natalia LomakinaNatalia Lomakina
Natalia Lomakina
EBElizaveta Y. Boravleva
Elizaveta Y. Boravleva
EKEkaterina A. Kropotkina
Ekaterina A. Kropotkina
VMVadim V. Mashin
Vadim V. Mashin
LRLarisa G. Rudenko
Larisa G. Rudenko
Please cite this paper as: Gambaryan et al. (2011) Comparative safety, immunogenicity, and efficacy of several anti‐H5N1 influenza experimental vaccines in a mouse and chicken models. Parallel testing of killed and live H5 vaccine. Influenza and Other Respiratory Viruses 6(3), 188–195.Objective  Parallel testing of inactivated (split and whole virion) and live vaccine was conducted to compare the immunogenicity and protective efficacy against homologous and heterosubtypic challenge by H5N1 highly pathogenic avian influenza virus.Method  Four experimental live vaccines based on two H5N1 influenza virus strains were tested; two of them had hemagglutinin (HA) of A/Vietnam/1203/04 strain lacking the polybasic HA cleavage site, and two others had hemagglutinins from attenuated H5N1 virus A/Chicken/Kurgan/3/05, with amino acid substitutions of Asp54/Asn and Lys222/Thr in HA1 and Val48/Ile and Lys131/Thr in HA2 while maintaining the polybasic HA cleavage site. The neuraminidase and non‐glycoprotein genes of the experimental live vaccines were from H2N2 cold‐adapted master strain A/Leningrad/134/17/57 (VN‐Len and Ku‐Len) or from the apathogenic H6N2 virus A/Gull/Moscow/3100/2006 (VN‐Gull and Ku‐Gull). Inactivated H5N1 and H1N1 and live H1N1 vaccine were used for comparison. All vaccines were applied in a single dose. Safety, immunogenicity, and protectivity against the challenge with HPAI H5N1 virus A/Chicken/Kurgan/3/05 were estimated.Results  All experimental live H5 vaccines tested were apathogenic as determined by weight loss and conferred more than 90% protection against lethal challenge with A/Chicken/Kurgan/3/05 infection. Inactivated H1N1 vaccine in mice offered no protection against challenge with H5N1 virus, while live cold‐adapted H1N1 vaccine reduced the mortality near to zero level.Conclusions  The high yield, safety, and protectivity of VN‐Len and Ku‐Len made them promising strains for the production of inactivated and live vaccines against H5N1 viruses.

1 July 2018 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
AGAlexandra Gambaryan
Alexandra Gambaryan
Natalia LomakinaNatalia Lomakina
Natalia Lomakina
EBE. Y. Boravleva
E. Y. Boravleva
LML. V. Mochalova
L. V. Mochalova
GSG. K. Sadykova
G. K. Sadykova
MMMikhail Matrosovich
Mikhail Matrosovich
To study the pathogenicity factors of the pandemic A(H1N1) influenza virus, a number of mutant variants of the A/Hamburg/5/2009 (H1N1)pdm09 strain were obtained through passage in chicken embryos,...

1 July 2012 in Molecular Genetics, Microbiology and Virology
Verified
Journal Article
Closed access
PDF file
Natalia LomakinaNatalia Lomakina
Natalia Lomakina
YBYu. M. Batuev
Yu. M. Batuev
The sacbrood virus (SBV) causes the death of honeybee larvae. Until recently, three SBV genotypes were known: European, Asian, and South African [7, 9]. Serological assay, sequencing, and phylogenetic analysis of the SBV RNA polymerase gene fragment have revealed two genotypes of SBV circulating among honeybee Apis mellifera in the European region of the Russian Federation (RF); one of them forms an independent, not previously described genetic lineage (genotype 4), which occupies an intermediate position on the phylogenetic tree between the Asian and the South African virus genotypes. The strain 202/8 isolated in 2006 in Moscow oblast from honeybees previously imported from Uzbekistan and two variants (Tr5 and 6/A3) of the laboratory strain isolated in Kaluga oblast in 1986 belong to this group of viruses. The homology between them is 94.2%, while that with representatives of other groups does not exceed 80.6–83.5%. Another group of SBVs comprise European genotype viruses circulating in Stavropol krai, Adygea, and Moscow oblast (isolates 207/4 and 212/3). The homology between them is 99%. The two SBV genotypes found in the RF were differentiated by PCR and RID (radial immunodiffusion test). As for RID, both genotypes react with antiserum no. 6(1), but only the fourth genotype reacts with antiserum no. 58.

1 November 2020 in Molecular Biology
Verified
Journal Article
Closed access
PDF file
TTTatyana A. Timofeeva
Tatyana A. Timofeeva
GSG. K. Sadykova
G. K. Sadykova
Natalia LomakinaNatalia Lomakina
Natalia Lomakina
AGA. S. Gambaryan
A. S. Gambaryan
IRI. A. Rudneva
I. A. Rudneva
APA. G. Prilipov
A. G. Prilipov
The continued circulation of influenza A virus subtype H5 may cause the emergence of new potential pandemic virus variants, which can be transmitted from person to person. The occurrence of such variants is mainly related to mutations in hemagglutinin (HA). Previously we discovered mutations in H5N1 influenza virus hemagglutinin, which contributes to virus immune evasion. The purpose of this work was to study the role of these mutations in changing other, non-antigenic properties of the virus and the possibility of their maintenance in the viral population. Mutations were introduced into the HA gene of a recombinant H5N1 influenza A virus (VNH5N1-PR8/CDC-RG) using site-specific mutagenesis. The “variant” viruses were investigated and compared with respect to replication kinetics in chicken embryos, thermostability, reproductive activity at different temperatures (33, 37 and 40°C), and virulence for mice. Amino acid substitutions I155T, K156Q, K156E+V138A, N186K led to a decrease in thermal stability, replication activity of the mutant viruses in chicken embryos, and virulence for mice, although these effects differed between the variants. The K156Q and N186K mutations reduced viral reproduction at elevated temperature (40°C). The analysis of the frequency of these mutations in natural isolates of H5N1 influenza viruses indicated that the K156E/Q and N186K mutations have little chance to gain a foothold during evolution, in contrast to the I155T mutation, which is the most responsible for antigenic drift. The A138V and N186K mutations seem to be adaptive in mammalian viruses.